Aleksei Valerianovich Shchegolev
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Aleksei Valerianovich Shchegolev has a total of 451 co-authors. Here are the top co-authors by number of shared publications:
- Igor Borisovich Zabolotskikh
Kuban State Medical University, Krasnodar, Russia; Krasnodar Regional Clinical Hospital No. 2, Krasnodar, Russia; Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, Russia
23 shared publications - Roman E. Lakhin
Kirov Military Medical Academy; Saratov State Medical University named after V.I. Razumovsky
21 shared publications - Konstantin M. Lebedinskii
Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, Russia; North-Western State Medical University named after I.I. Mechnikov, St. Petersburg, Russia
16 shared publications - Andrey Avgustovich Belkin
Ural State Medical University
15 shared publications - Denis Nikolaevich Protsenko
Pirogov Russian National Research Medical University
15 shared publications - Alexey I. Gritsan
Voino-Yasenetsky Krasnoyarsk State Medical University, Krasnoyarsk, Russia
11 shared publications
Latest Publications
- Open Access
- 31 October 2026
- Published by Practical Medicine Publishing House in Annals of Critical Care
- No. 4,p. 173-185
Effect of infusion of 0.9 % sodium chloride solution and meglumine sodium succinate on acid‑base status in trauma patients: a randomized comparative study
INTRODUCTION: Blood loss in severe trauma leads to shock, microcirculatory disorders, and disturbances of acid-base status (ABS). Initial resuscitation uses crystalloids that affect ABS. OBJECTIVE: To compare the effects of 0.9 % saline vs. meglumine sodium succinate (Reamberin®) on ABS and electrolyte balance in patients with severe trauma. MATERIALS AND METHODS: Prospective randomized trial of 30 patients (15 per group). Group 1 received 1000 mL 0.9 % NaCl, Group 2 — 1000 mL meglumine sodium succinate. ABS, electrolytes, anion gap (AG), and strong ion difference (SID) were measured before and after infusion. RESULTS: After infusion, the meglumine sodium succinate group showed significantly better ABS: pH 7.386 (7.294; 7.498) vs 7.242 (7.203; 7.336); p = 0.013; HCO3− 24.50 (20.31; 27.90) vs 19.80 (15.37; 22.30) mmol/L; p = 0.018; BE 1.10 (−5.81; 2.52) vs −6.60 (−12.68; −3.08) mmol/L; p = 0.007. In the 0.9 % NaCl group, chloride increased from 105.2 to 110.4 mmol/L (p = 0.03) and AG increased (p = 0.01). CONCLUSIONS: Infusion of meglumine sodium succinate in patients with severe trauma and uncompensated blood loss provides effective correction of metabolic acidosis, as confirmed by normalization of pH, HCO3-act, BE, as well as favorable dynamics of anion gap and stable strong ion difference. The use of 0.9 % sodium chloride solution is associated with worsening acidosis and development of hyperchloremic disorders, as evidenced by increased chloride levels, decreased strong ion difference, and elevated anion gap.
- 31 October 2026
- Published by Practical Medicine Publishing House in Annals of Critical Care
- No. 4,p. 173-185
Open AccessEffect of infusion of 0.9 % sodium chloride solution and meglumine sodium succinate on acid‑base status in trauma patients: a randomized comparative study
INTRODUCTION: Blood loss in severe trauma leads to shock, microcirculatory disorders, and disturbances of acid-base status (ABS). Initial resuscitation uses crystalloids that affect ABS. OBJECTIVE: To compare the effects of 0.9 % saline vs. meglumine sodium succinate (Reamberin®) on ABS and electrolyte balance in patients with severe trauma. MATERIALS AND METHODS: Prospective randomized trial of 30 patients (15 per group). Group 1 received 1000 mL 0.9 % NaCl, Group 2 — 1000 mL meglumine sodium succinate. ABS, electrolytes, anion gap (AG), and strong ion difference (SID) were measured before and after infusion. RESULTS: After infusion, the meglumine sodium succinate group showed significantly better ABS: pH 7.386 (7.294; 7.498) vs 7.242 (7.203; 7.336); p = 0.013; HCO3− 24.50 (20.31; 27.90) vs 19.80 (15.37; 22.30) mmol/L; p = 0.018; BE 1.10 (−5.81; 2.52) vs −6.60 (−12.68; −3.08) mmol/L; p = 0.007. In the 0.9 % NaCl group, chloride increased from 105.2 to 110.4 mmol/L (p = 0.03) and AG increased (p = 0.01). CONCLUSIONS: Infusion of meglumine sodium succinate in patients with severe trauma and uncompensated blood loss provides effective correction of metabolic acidosis, as confirmed by normalization of pH, HCO3-act, BE, as well as favorable dynamics of anion gap and stable strong ion difference. The use of 0.9 % sodium chloride solution is associated with worsening acidosis and development of hyperchloremic disorders, as evidenced by increased chloride levels, decreased strong ion difference, and elevated anion gap.
- Open Access
- 31 July 2026
- Published by Practical Medicine Publishing House in Annals of Critical Care
- No. 3,p. 160-170
Clinical competence and team roles of anaesthetic nurses: results of a multicenter cross-sectional study
INTRODUCTION: Nurse anesthetists play a critical role in ensuring patient safety during the perioperative period; however, their clinical competence and role within the team remain insufficiently studied at the national level. OBJECTIVE: To assess the self-reported level of clinical competence among nurse anesthetists, its association with years of professional experience and qualification category, and to identify their predominant team roles. MATERIALS AND METHODS: A multicenter cross-sectional study was conducted among nurse anesthetists. A structured 34-item questionnaire was used, comprising the following sections: socio-professional characteristics, self-assessment of clinical competence, and team roles based on the Belbin Team Roles Inventory. Clinical competence was assessed on a scale from 0 to 100; a predefined threshold was used to classify respondents as competent. Statistical methods includes: χ2 test, Kendall’s tau (τ), and Spearman’s rank correlation coefficient (rs) with 95 % confidence intervals. Statistical significance was set at p < 0.05. RESULTS: A total of 172 respondents were included in the study (median age 42 years, interquartile range 33–49). Only 17.8 % of nurses with limited work experience (< 5 years) reached the competence threshold, compared with 43.6 % in the group with 6–10 years of experience, followed by a decline in more experienced groups, indicating a non-linear relationship between clinical competence and years of experience. No consistent linear correlation was found between work experience and competence scores. Work experience showed a moderate correlation with age and qualification category, but only a weak correlation with competence. CONCLUSIONS: The traditional linear paradigm “experience → qualification category → competence” appears to be ambiguous in the development of professional competence among nurses. The findings support the need to shift from formal consideration of years of experience toward continuous professional development, including regular objective skills assessment, simulation-based training, and consideration of team role profiles in workforce organization.
- 31 July 2026
- Published by Practical Medicine Publishing House in Annals of Critical Care
- No. 3,p. 160-170
Open AccessClinical competence and team roles of anaesthetic nurses: results of a multicenter cross-sectional study
INTRODUCTION: Nurse anesthetists play a critical role in ensuring patient safety during the perioperative period; however, their clinical competence and role within the team remain insufficiently studied at the national level. OBJECTIVE: To assess the self-reported level of clinical competence among nurse anesthetists, its association with years of professional experience and qualification category, and to identify their predominant team roles. MATERIALS AND METHODS: A multicenter cross-sectional study was conducted among nurse anesthetists. A structured 34-item questionnaire was used, comprising the following sections: socio-professional characteristics, self-assessment of clinical competence, and team roles based on the Belbin Team Roles Inventory. Clinical competence was assessed on a scale from 0 to 100; a predefined threshold was used to classify respondents as competent. Statistical methods includes: χ2 test, Kendall’s tau (τ), and Spearman’s rank correlation coefficient (rs) with 95 % confidence intervals. Statistical significance was set at p < 0.05. RESULTS: A total of 172 respondents were included in the study (median age 42 years, interquartile range 33–49). Only 17.8 % of nurses with limited work experience (< 5 years) reached the competence threshold, compared with 43.6 % in the group with 6–10 years of experience, followed by a decline in more experienced groups, indicating a non-linear relationship between clinical competence and years of experience. No consistent linear correlation was found between work experience and competence scores. Work experience showed a moderate correlation with age and qualification category, but only a weak correlation with competence. CONCLUSIONS: The traditional linear paradigm “experience → qualification category → competence” appears to be ambiguous in the development of professional competence among nurses. The findings support the need to shift from formal consideration of years of experience toward continuous professional development, including regular objective skills assessment, simulation-based training, and consideration of team role profiles in workforce organization.
- Open Access
- 4 June 2026
- Published by ECO-Vector LLC (Publications) in Regional Anesthesia and Acute Pain Management
- Vol. 20 (2) , 159-165
Proximal costoclavicular block for upper extremity trauma and injury surgery in patients with uncompensated blood loss: a case series
Introduction: The proximal costoclavicular approach to the brachial plexus is considered an anatomically advantageous alternative to the classical infraclavicular approach due to the compact arrangement of all three cords within a single fascial sheath. This potentially provides a faster and more predictable onset of the block and reduces the risk of complications. However, data from comparative studies on the speed of sensory and motor block onset remain contradictory, and clinical experience with this technique in routine practice requires further accumulation. Case description: This article presents a case series of 32 patients (median age 38 years) who underwent upper limb surgery (elbow region—8 cases, forearm—16 cases, hand—8 cases). All patients received a brachial plexus block using the proximal costoclavicular approach under ultrasound guidance (LOGIQ system, 12L-RS probe). A mixture of local anesthetics was used: 10 mL of 0.75% ropivacaine and 6 mL of 2% lidocaine (total volume 16 mL). The efficacy of the block was assessed every 5 minutes for 30 minutes post-injection using a 3-point scale. Successful sensory block was achieved in 31 patients (96.9%). The median time to achieve complete sensory anesthesia was 10 minutes [Q1; Q3: 8; 13], and complete motor palsy was 15 minutes [12; 18]. In 5 patients (15.6%), visualization of the cords was suboptimal; however, the block was successful in 4 of them (80%). No complications such as Horner’s syndrome, dysphonia, pneumothorax, or diaphragm paresis were recorded. Conclusion: This case series demonstrates that ultrasound-guided costoclavicular block is a highly effective (96.9%) and safe method of regional anesthesia. The technique provides a predictable block onset time (10–15 minutes) and can be successfully performed even under conditions of suboptimal anatomical visualization. These findings are consistent with the results of recent systematic reviews and confirm the clinical value of the costoclavicular approach in anesthesiology practice.
- 4 June 2026
- Published by ECO-Vector LLC (Publications) in Regional Anesthesia and Acute Pain Management
- Vol. 20 (2) , 159-165
Open AccessProximal costoclavicular block for upper extremity trauma and injury surgery in patients with uncompensated blood loss: a case series
Introduction: The proximal costoclavicular approach to the brachial plexus is considered an anatomically advantageous alternative to the classical infraclavicular approach due to the compact arrangement of all three cords within a single fascial sheath. This potentially provides a faster and more predictable onset of the block and reduces the risk of complications. However, data from comparative studies on the speed of sensory and motor block onset remain contradictory, and clinical experience with this technique in routine practice requires further accumulation. Case description: This article presents a case series of 32 patients (median age 38 years) who underwent upper limb surgery (elbow region—8 cases, forearm—16 cases, hand—8 cases). All patients received a brachial plexus block using the proximal costoclavicular approach under ultrasound guidance (LOGIQ system, 12L-RS probe). A mixture of local anesthetics was used: 10 mL of 0.75% ropivacaine and 6 mL of 2% lidocaine (total volume 16 mL). The efficacy of the block was assessed every 5 minutes for 30 minutes post-injection using a 3-point scale. Successful sensory block was achieved in 31 patients (96.9%). The median time to achieve complete sensory anesthesia was 10 minutes [Q1; Q3: 8; 13], and complete motor palsy was 15 minutes [12; 18]. In 5 patients (15.6%), visualization of the cords was suboptimal; however, the block was successful in 4 of them (80%). No complications such as Horner’s syndrome, dysphonia, pneumothorax, or diaphragm paresis were recorded. Conclusion: This case series demonstrates that ultrasound-guided costoclavicular block is a highly effective (96.9%) and safe method of regional anesthesia. The technique provides a predictable block onset time (10–15 minutes) and can be successfully performed even under conditions of suboptimal anatomical visualization. These findings are consistent with the results of recent systematic reviews and confirm the clinical value of the costoclavicular approach in anesthesiology practice.
- Open Access
- 29 May 2026
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 7,p. 8-21
Preoperative management algorithm for endoscopic or surgical interventions in patients receiving incretin mimetics
The widespread use of GIP and/or GLP-1 receptor agonists for the treatment of type 2 diabetes mellitus and obesity has introduced new challenges in the perioperative period. These agents induce delayed gastric emptying, rendering traditional preoperative fasting protocols less effective and significantly increasing the risk of pulmonary aspiration of residual gastric contents. Suppression of the migrating motor complex leads to the retention of solids and liquids in the stomach far beyond standard physiological durations. Current recommendations regarding the pre-procedural prophylactic withdrawal of these drugs carry the risk of losing glycemic and metabolic control, as the long half-life of weekly formulations would require a treatment hiatus exceeding 4–5 weeks. Based on a literature review and clinical experience, this article proposes a novel perioperative management approach that avoids interrupting targeted incretin mimetic therapy. This strategy is based on preliminary aspiration risk stratification: Low-risk group (patients on stable, asymptomatic therapy): Validates a preventive combined preparation consisting of a 24-hour clear liquid diet in conjunction with prophylactic prokinetics to actively overcome gastric atony and stimulate emptying. High-risk group (presence of dyspepsia, initiation or dose escalation phase, morbid obesity): This pharmacological and dietary preparation is mandatory and must be supplemented by Point-of-Care Ultrasound (POCUS) of the stomach on the day of the intervention. The implementation of this dual strategy – pharmacological/dietary motility correction and ultrasound monitoring – reliably minimizes delayed gastric emptying and the risk of bronchopulmonary aspiration without depriving patients of the positive effects of weight-loss and cardiometabolic therapy.
- 29 May 2026
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 7,p. 8-21
Open AccessPreoperative management algorithm for endoscopic or surgical interventions in patients receiving incretin mimetics
The widespread use of GIP and/or GLP-1 receptor agonists for the treatment of type 2 diabetes mellitus and obesity has introduced new challenges in the perioperative period. These agents induce delayed gastric emptying, rendering traditional preoperative fasting protocols less effective and significantly increasing the risk of pulmonary aspiration of residual gastric contents. Suppression of the migrating motor complex leads to the retention of solids and liquids in the stomach far beyond standard physiological durations. Current recommendations regarding the pre-procedural prophylactic withdrawal of these drugs carry the risk of losing glycemic and metabolic control, as the long half-life of weekly formulations would require a treatment hiatus exceeding 4–5 weeks. Based on a literature review and clinical experience, this article proposes a novel perioperative management approach that avoids interrupting targeted incretin mimetic therapy. This strategy is based on preliminary aspiration risk stratification: Low-risk group (patients on stable, asymptomatic therapy): Validates a preventive combined preparation consisting of a 24-hour clear liquid diet in conjunction with prophylactic prokinetics to actively overcome gastric atony and stimulate emptying. High-risk group (presence of dyspepsia, initiation or dose escalation phase, morbid obesity): This pharmacological and dietary preparation is mandatory and must be supplemented by Point-of-Care Ultrasound (POCUS) of the stomach on the day of the intervention. The implementation of this dual strategy – pharmacological/dietary motility correction and ultrasound monitoring – reliably minimizes delayed gastric emptying and the risk of bronchopulmonary aspiration without depriving patients of the positive effects of weight-loss and cardiometabolic therapy.
- 4 March 2026
- Published by Postgraduate Institute for Public Health Worker under Health Ministry of Khabarovsk Krai in Public health of the Far East Peer-reviewed scientific and practical journal
- Vol. 1 (107)
Dynamics of hemostasis and inflammation parameters as a prognostic factor for mortality in severe combined trauma: a retrospective cohort study
Objective: To establish the prognostic significance of changes in hemostasis parameters and systemic inflammation markers during the first 72 hours at the fifth stage of medical care for assessing the risk of mortality in patients with severe combined trauma. Material and Methods: Data from 59 patients with severe combined trauma (ISS ≥20) admitted to the intensive care unit on the 6th [5–8th] day after injury were analyzed. Patients were divided into groups of survivors (n = 37) and deceased (n = 22). Clinical and laboratory parameters were assessed upon admission and on the 3rd day. Results: at admission, the groups differed in the severity of thrombocytopenia (98.9 [71.5; 186.9] versus 185.0 [113.8; 279.5] ×10⁹/l, p = 0.011) and hypocoagulation as measured by a decrease in the prothrombin index (PTI) (70.9 [48.8; 83.5] versus 93.2 [66.0; 112.5] %, p = 0.004). By the 3rd day, hypocoagulation persisted in the group of deceased (PTI 73.5 ± 18.5 % versus 99.6 ± 27.0 %, p < 0.001) against the background of a significant increase in the level of C-reactive protein (CRP) (213.2 ± 110.2 mg/l versus 147.5 ± 72.1 mg/l, p = 0.014). Multivariate analysis revealed independent predictors of mortality: thrombocytopenia (<150 × 10⁹/L; OR = 3.91; 95 % CI: 1.25–12.91; p = 0.02), high SOFA score (OR = 1.17; 95 % CI: 1.01–1.36; p = 0.03), and decreased PTI (<76 %; OR = 3.52; 95 % CI: 1.15–10.75; p = 0.03). Conclusion: in patients with severe concomitant trauma, poor outcome in the late stages of treatment is associated with progression of coagulopathy against the background of increasing systemic inflammation, which indicates the development of secondary sepsis-associated coagulopathy. Monitoring platelet, PTI, CRP, and procalcitonin dynamics in the first 72 hours allows for risk stratification and timely therapy adjustments.
- 4 March 2026
- Published by Postgraduate Institute for Public Health Worker under Health Ministry of Khabarovsk Krai in Public health of the Far East Peer-reviewed scientific and practical journal
- Vol. 1 (107)
Dynamics of hemostasis and inflammation parameters as a prognostic factor for mortality in severe combined trauma: a retrospective cohort study
Objective: To establish the prognostic significance of changes in hemostasis parameters and systemic inflammation markers during the first 72 hours at the fifth stage of medical care for assessing the risk of mortality in patients with severe combined trauma. Material and Methods: Data from 59 patients with severe combined trauma (ISS ≥20) admitted to the intensive care unit on the 6th [5–8th] day after injury were analyzed. Patients were divided into groups of survivors (n = 37) and deceased (n = 22). Clinical and laboratory parameters were assessed upon admission and on the 3rd day. Results: at admission, the groups differed in the severity of thrombocytopenia (98.9 [71.5; 186.9] versus 185.0 [113.8; 279.5] ×10⁹/l, p = 0.011) and hypocoagulation as measured by a decrease in the prothrombin index (PTI) (70.9 [48.8; 83.5] versus 93.2 [66.0; 112.5] %, p = 0.004). By the 3rd day, hypocoagulation persisted in the group of deceased (PTI 73.5 ± 18.5 % versus 99.6 ± 27.0 %, p < 0.001) against the background of a significant increase in the level of C-reactive protein (CRP) (213.2 ± 110.2 mg/l versus 147.5 ± 72.1 mg/l, p = 0.014). Multivariate analysis revealed independent predictors of mortality: thrombocytopenia (<150 × 10⁹/L; OR = 3.91; 95 % CI: 1.25–12.91; p = 0.02), high SOFA score (OR = 1.17; 95 % CI: 1.01–1.36; p = 0.03), and decreased PTI (<76 %; OR = 3.52; 95 % CI: 1.15–10.75; p = 0.03). Conclusion: in patients with severe concomitant trauma, poor outcome in the late stages of treatment is associated with progression of coagulopathy against the background of increasing systemic inflammation, which indicates the development of secondary sepsis-associated coagulopathy. Monitoring platelet, PTI, CRP, and procalcitonin dynamics in the first 72 hours allows for risk stratification and timely therapy adjustments.
- Open Access
- 29 December 2025
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in Messenger of ANESTHESIOLOGY AND RESUSCITATION
- Vol. 22 (6) , 86-96
Clinical indicators of the efficacy of therapy with olokizumab in patients with COVID-19 infection
Introduction. A new form of coronavirus δ (SARS-CoV-2) caused the development of the global COVID-19 pandemic in 2019–2022, which claimed more than 7 million lives. COVID-19 infection is accompanied by a rapid deterioration in the health of patients with the development of a generalized systemic inflammatory response due to increased production of cytokines (IL-1β, IL-6, IL-18, IFN-γ) is a cytokine storm (CS). To relieve this condition, it is proposed to use monoclonal antibodies against IL-6 – tocilizumab, olokizumab. The objective was to investigate the clinical efficacy of the inhibitor of IL-6 (olokizumab) against the background of standard (basic) therapy in patients with severe COVID-19 infection. Materials and methods. A single-center clinical retrospective study included 266 patients (124 men and 142 women, aged 19–103, 70.7 ± 15.4 years) who had a positive PCR test result for the presence of SARS-CoV-2 RNA and were treated at the City Hospital No. 40 of the Kurortny District of St. Petersburg in 2020–2024. The main endpoints of the study were biological death or discharge from the intensive care unit (ICU). All patients received basic antibacterial and antiviral therapy with favipiravir or remdesivir. Olokizumab (n = 87) was used in 103 patients with CS. Results. The use of olokizumab was accompanied by a decrease in the degree of respiratory failure (0.11 ± 0.05 points versus 1.94 ± 0.23 points, p < 0.000001), the number of points on the NEWS scale (0.59 ± 0.10 versus 6.41 ± 0.84 points, p < 0.000001), the form of the disease according to CT (1.79 ± 0.09 versus 3.27 ± 0.30 points, p < 0.000001), as well as the percentage of hydrothorax (26.4 ± 5.0% versus 64.7 ± 11.0%, p < 0.0026) and the comorbidity index (3.88 ± 0.31 versus 6.17 ± 0.66 points, p < 0.0018) in discharged patients compared to the fatal outcome group. In addition, olokizumab therapy was accompanied by a significant decrease in IL-6 levels by day 3 in both discharged (42.19 ± 6.29 pg/ml, p < 0.0001) and fatal (83.64 ± 22.769 pg/ml, p = 0.004658) patients compared to baseline values upon admission. There was a significant decrease in IL-6 levels in discharged patients compared to the fatal group (p = 0.002415). An increase in IL-6 levels above 50 pg/ml in COVID-19 patients treated with olokizumab was statistically significantly (p = 0.0002) associated with a 14.3 – fold increase in the risk of death. An increase in the respiratory failure degree over 1 point, NEWS morbidity level over 4–5 points, CT disease form over 2 points, and comorbidity index over 5 points increased the risk of death in patients receiving olokizumab by 7.4, 91.1, 6.2, and 12.6 times, respectively. Olokizumab administration resulted in a discharge rate of 80.5% (n = 70, p < 0.0001). Conclusions. The use of olokizumab in patients with severe COVID-19 was effective in terms of clinical parameters: the degree of respiratory failure, the number of points on the NEWS scale, the form of the disease on CT, the percentage of hydrothorax and the comorbidity index, as well as the level of IL-6, which can be used as criteria for the effectiveness of therapy in patients with COVID-19.
- 29 December 2025
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in Messenger of ANESTHESIOLOGY AND RESUSCITATION
- Vol. 22 (6) , 86-96
Open AccessClinical indicators of the efficacy of therapy with olokizumab in patients with COVID-19 infection
Introduction. A new form of coronavirus δ (SARS-CoV-2) caused the development of the global COVID-19 pandemic in 2019–2022, which claimed more than 7 million lives. COVID-19 infection is accompanied by a rapid deterioration in the health of patients with the development of a generalized systemic inflammatory response due to increased production of cytokines (IL-1β, IL-6, IL-18, IFN-γ) is a cytokine storm (CS). To relieve this condition, it is proposed to use monoclonal antibodies against IL-6 – tocilizumab, olokizumab. The objective was to investigate the clinical efficacy of the inhibitor of IL-6 (olokizumab) against the background of standard (basic) therapy in patients with severe COVID-19 infection. Materials and methods. A single-center clinical retrospective study included 266 patients (124 men and 142 women, aged 19–103, 70.7 ± 15.4 years) who had a positive PCR test result for the presence of SARS-CoV-2 RNA and were treated at the City Hospital No. 40 of the Kurortny District of St. Petersburg in 2020–2024. The main endpoints of the study were biological death or discharge from the intensive care unit (ICU). All patients received basic antibacterial and antiviral therapy with favipiravir or remdesivir. Olokizumab (n = 87) was used in 103 patients with CS. Results. The use of olokizumab was accompanied by a decrease in the degree of respiratory failure (0.11 ± 0.05 points versus 1.94 ± 0.23 points, p < 0.000001), the number of points on the NEWS scale (0.59 ± 0.10 versus 6.41 ± 0.84 points, p < 0.000001), the form of the disease according to CT (1.79 ± 0.09 versus 3.27 ± 0.30 points, p < 0.000001), as well as the percentage of hydrothorax (26.4 ± 5.0% versus 64.7 ± 11.0%, p < 0.0026) and the comorbidity index (3.88 ± 0.31 versus 6.17 ± 0.66 points, p < 0.0018) in discharged patients compared to the fatal outcome group. In addition, olokizumab therapy was accompanied by a significant decrease in IL-6 levels by day 3 in both discharged (42.19 ± 6.29 pg/ml, p < 0.0001) and fatal (83.64 ± 22.769 pg/ml, p = 0.004658) patients compared to baseline values upon admission. There was a significant decrease in IL-6 levels in discharged patients compared to the fatal group (p = 0.002415). An increase in IL-6 levels above 50 pg/ml in COVID-19 patients treated with olokizumab was statistically significantly (p = 0.0002) associated with a 14.3 – fold increase in the risk of death. An increase in the respiratory failure degree over 1 point, NEWS morbidity level over 4–5 points, CT disease form over 2 points, and comorbidity index over 5 points increased the risk of death in patients receiving olokizumab by 7.4, 91.1, 6.2, and 12.6 times, respectively. Olokizumab administration resulted in a discharge rate of 80.5% (n = 70, p < 0.0001). Conclusions. The use of olokizumab in patients with severe COVID-19 was effective in terms of clinical parameters: the degree of respiratory failure, the number of points on the NEWS scale, the form of the disease on CT, the percentage of hydrothorax and the comorbidity index, as well as the level of IL-6, which can be used as criteria for the effectiveness of therapy in patients with COVID-19.
- Open Access
- 26 December 2025
- Published by ECO-Vector LLC in Clinical nutrition and metabolism
- Vol. 6 (4) , 181-188
The impact of early enteral nutrition on the acute phase of severe psychoactive substance poisoning: a prospective randomized clinical study
BACKGROUND: Enteral nutrition during the acute phase of poisoning with psychoactive substances is an integral component of intensive care. However, its effectiveness remains understudied. AIM: This study aimed to evaluate the effectiveness of early enteral nutrition in patients with severe acute poisoning by psychoactive substances. METHODS: The study included 36 patients treated in the intensive care unit (ICU) for acute poisoning with psychoactive substances. Patients were randomized into two groups. In the first (main) group, enteral nutrition was initiated within 24 hours of ICU admission. In the control group, enteral nutrition was started after 36 hours. In all patients, neurological status trends were assessed using the FOUR (Full Outline of UnResponsiveness) score; the number of days to liberation from mechanical ventilation and ICU length of stay were recorded. Plasma albumin and total protein concentrations were also analyzed. RESULTS: On day 3, neurological deficit in the control group was 12 (10; 14) points on the FOUR scale. This indicator was significantly lower than in the main group—15 (14; 16) points (p = 0.006). No significant differences between groups were observed on day 1. Plasma total protein and albumin concentrations did not differ between groups on day 1. By day 3, total protein concentration was significantly higher in the main group (62.48 ± 5.77 g/L) compared with the control group (55.34 ± 5.28 g/L, p = 0.001). Albumin concentration was also higher in the main group: 39.55 ± 3.75 g/L vs 34.48 ± 4.51 g/L (p = 0.002). No significant association was found between the timing of enteral nutrition initiation and the duration of mechanical ventilation or ICU stay. CONCLUSION: Early enteral nutrition in patients with severe poisoning by psychoactive substances significantly increases plasma albumin and total protein levels and contributes to faster neurological recovery. No significant effect of enteral nutrition timing on ICU length of stay or duration of mechanical ventilation was observed.
- 26 December 2025
- Published by ECO-Vector LLC in Clinical nutrition and metabolism
- Vol. 6 (4) , 181-188
Open AccessThe impact of early enteral nutrition on the acute phase of severe psychoactive substance poisoning: a prospective randomized clinical study
BACKGROUND: Enteral nutrition during the acute phase of poisoning with psychoactive substances is an integral component of intensive care. However, its effectiveness remains understudied. AIM: This study aimed to evaluate the effectiveness of early enteral nutrition in patients with severe acute poisoning by psychoactive substances. METHODS: The study included 36 patients treated in the intensive care unit (ICU) for acute poisoning with psychoactive substances. Patients were randomized into two groups. In the first (main) group, enteral nutrition was initiated within 24 hours of ICU admission. In the control group, enteral nutrition was started after 36 hours. In all patients, neurological status trends were assessed using the FOUR (Full Outline of UnResponsiveness) score; the number of days to liberation from mechanical ventilation and ICU length of stay were recorded. Plasma albumin and total protein concentrations were also analyzed. RESULTS: On day 3, neurological deficit in the control group was 12 (10; 14) points on the FOUR scale. This indicator was significantly lower than in the main group—15 (14; 16) points (p = 0.006). No significant differences between groups were observed on day 1. Plasma total protein and albumin concentrations did not differ between groups on day 1. By day 3, total protein concentration was significantly higher in the main group (62.48 ± 5.77 g/L) compared with the control group (55.34 ± 5.28 g/L, p = 0.001). Albumin concentration was also higher in the main group: 39.55 ± 3.75 g/L vs 34.48 ± 4.51 g/L (p = 0.002). No significant association was found between the timing of enteral nutrition initiation and the duration of mechanical ventilation or ICU stay. CONCLUSION: Early enteral nutrition in patients with severe poisoning by psychoactive substances significantly increases plasma albumin and total protein levels and contributes to faster neurological recovery. No significant effect of enteral nutrition timing on ICU length of stay or duration of mechanical ventilation was observed.
- 22 October 2025
- Published by Media Sphere Publishing Group in Russian Journal of Anesthesiology and Reanimatology
- No. 5,p. 22-27
Leukocyte telomere length changes following various anesthetic methods in patients with severe combined trauma
Background. In recent decades, the number of surgical interventions has increased in the world. In clinical practice, it is not always possible to assess long-term changes/complications/outcomes. The other side of technological progress includes patient satisfaction with medical care and desire for active longevity. Quality and safety of anesthesia, as well as its impact on humans are actively discussed in global community. Epigenetics is one of the new directions in anesthesiology. At the moment, the effect of anesthesia on genome is not established. Objective. To study leukocyte telomere length in patients with severe concomitant trauma undergoing repeated anesthesia. Material and methods. A prospective cohort study included 41 victims with severe combined trauma. The first group included patients who underwent regional anesthesia with propofol sedation (RA), the second group — general combined anesthesia (GA). Twice blood sampling was performed for laboratory diagnostics. We analyzed leukocyte telomere length using real-time PCR before treatment and 4 weeks after admission. Results. There were no significant between-group differences after 4 weeks (p=0.933). In the first group, there was significantly shorter leukocyte telomere length in 4 weeks after admission (p=0.002282). Conclusion. General anesthesia does not affect the length of leucocyte telomeres. Telomere shortening was observed after regional anesthesia, but appropriate values were within normal limits. Probably, this shortening was short-term, and restoration of baseline telomere length is possible. It is not possible to answer the question about the causes of telomere shortening unambiguously. Further studies of epigenetic aspects of anesthesiology are needed.
- 22 October 2025
- Published by Media Sphere Publishing Group in Russian Journal of Anesthesiology and Reanimatology
- No. 5,p. 22-27
Leukocyte telomere length changes following various anesthetic methods in patients with severe combined trauma
Background. In recent decades, the number of surgical interventions has increased in the world. In clinical practice, it is not always possible to assess long-term changes/complications/outcomes. The other side of technological progress includes patient satisfaction with medical care and desire for active longevity. Quality and safety of anesthesia, as well as its impact on humans are actively discussed in global community. Epigenetics is one of the new directions in anesthesiology. At the moment, the effect of anesthesia on genome is not established. Objective. To study leukocyte telomere length in patients with severe concomitant trauma undergoing repeated anesthesia. Material and methods. A prospective cohort study included 41 victims with severe combined trauma. The first group included patients who underwent regional anesthesia with propofol sedation (RA), the second group — general combined anesthesia (GA). Twice blood sampling was performed for laboratory diagnostics. We analyzed leukocyte telomere length using real-time PCR before treatment and 4 weeks after admission. Results. There were no significant between-group differences after 4 weeks (p=0.933). In the first group, there was significantly shorter leukocyte telomere length in 4 weeks after admission (p=0.002282). Conclusion. General anesthesia does not affect the length of leucocyte telomeres. Telomere shortening was observed after regional anesthesia, but appropriate values were within normal limits. Probably, this shortening was short-term, and restoration of baseline telomere length is possible. It is not possible to answer the question about the causes of telomere shortening unambiguously. Further studies of epigenetic aspects of anesthesiology are needed.
- Open Access
- 24 September 2025
- Published by The Scientific and Practical Society of Emergency Medicine Physicians in Russian Sklifosovsky Journal "Emergency Medical Care"
- Vol. 14 (3) , 619-627
On the Issue of Automation of Electronic Documentation in the Anesthesiology and Resuscitation Service
The current stage of healthcare development is characterized by the widespread introduction of medical information systems with the unification of technological processes and a complete transition to electronic document management; one of the most important components of which is the automatic maintenance of electronic medical records. However, today, real practice is facing a number of challenges and problems, the solution of which is becoming a top priority.The Aim of the Study. was to analyze the current state of digitalization of the anesthesiology and resuscitation (A&R) services in the country’s medical institutions towards the introduction of automated document management.Material and Methods. An expert assessment of the digitalization of A&R services (departments) of 235 multidisciplinary hospitals was conducted, including the evaluation of its level, leading components and their structure in the overall sample. Information from a multicenter questionnaire study approved by the Federation of Anaesthesiologists and Reanimatologists of Russia was used.Results. The study showed that the functionality of the medical information system in each particular hospital differs depending on the developer and the technical capabilities of the hospital itself. The study revealed that electronic document management in the field of A&R, including fully automated ones, is currently fraught with a number of problems (barriers), including technical difficulties, the need for staff training, issues of confidentiality and data security.Conclusions. Automated electronic document management requires a comprehensive solution to issues of hardware and software, connection of special equipment, and personnel training. In addition, the successful integration of electronic A&R records into medical practice requires active cooperation from all stakeholders: medical staff, IT specialists, medical institution administration, and health authorities.
- 24 September 2025
- Published by The Scientific and Practical Society of Emergency Medicine Physicians in Russian Sklifosovsky Journal "Emergency Medical Care"
- Vol. 14 (3) , 619-627
Open AccessOn the Issue of Automation of Electronic Documentation in the Anesthesiology and Resuscitation Service
The current stage of healthcare development is characterized by the widespread introduction of medical information systems with the unification of technological processes and a complete transition to electronic document management; one of the most important components of which is the automatic maintenance of electronic medical records. However, today, real practice is facing a number of challenges and problems, the solution of which is becoming a top priority.The Aim of the Study. was to analyze the current state of digitalization of the anesthesiology and resuscitation (A&R) services in the country’s medical institutions towards the introduction of automated document management.Material and Methods. An expert assessment of the digitalization of A&R services (departments) of 235 multidisciplinary hospitals was conducted, including the evaluation of its level, leading components and their structure in the overall sample. Information from a multicenter questionnaire study approved by the Federation of Anaesthesiologists and Reanimatologists of Russia was used.Results. The study showed that the functionality of the medical information system in each particular hospital differs depending on the developer and the technical capabilities of the hospital itself. The study revealed that electronic document management in the field of A&R, including fully automated ones, is currently fraught with a number of problems (barriers), including technical difficulties, the need for staff training, issues of confidentiality and data security.Conclusions. Automated electronic document management requires a comprehensive solution to issues of hardware and software, connection of special equipment, and personnel training. In addition, the successful integration of electronic A&R records into medical practice requires active cooperation from all stakeholders: medical staff, IT specialists, medical institution administration, and health authorities.
- 18 June 2025
- Published by SAGE Publications in Journal of Intensive Care Medicine
- Vol. 40 (11) , 1169-1176
Mortality Predictors in Stroke Patients Requiring Mechanical Ventilation: A Multicenter Prospective Observational Study
Background: Patients with acute severe stroke requiring mechanical ventilation represent a significant clinical challenge. Identification of mortality predictors is necessary to improve outcomes. Methods: Fourteen hospitals located around Russia participated in this prospective multicenter observational clinical study. Patients admitted to ICU between November 1, 2017, and November 1, 2019 with confirmed cerebral stroke, aged 18 to 90 years, and requiring mechanical ventilation were included. The impact of various clinical factors on mortality during the 28-day period after stroke was assessed. Results: A total of 1289 patients were included in the registry, and 1144 met the study criteria. The 28-day mortality rate for stroke patients on mechanical ventilation was 64.3%. The most common indications for mechanical ventilation were impaired consciousness (75.7%) and hypoxemia (60.9%). In the cohort of strokes with NIHSS severity greater than 20 points, hypoxemia at the start of ventilation (OR 1.85 [1.21; 2.81], P = 0.004) and the use of hyperventilation mode (OR 1.46 [1.02; 2.06], P = 0.0336) were associated with increased mortality. Pressure-controlled mode as the primary ventilation method (OR 0.36 [0.21; 0.60], P < 0.001) and ICP monitoring (OR 0.23 [0.12; 0.44], P < 0.001) were associated with decreased mortality. Infectious complications were associated with longer mechanical ventilation and ICU stay (P < 0.001). The relationship between probable mortality and the severity of neurological deficit on the NIHSS scale at the start of mechanical ventilation is non-linear. A critical threshold was reached at 16 points NIHSS, where a trend of increasing probable mortality emerged. Conclusion: The identified predictors of mortality in stroke patients requiring mechanical ventilation are essential for decision-making in this cohort. They include hypoxemia, hyperventilation (used to control intracranial hypertension), volume-controlled (VC) versus pressure-controlled (PC) initial ventilation, and the use of clinical methods for monitoring ICP alone versus invasive monitoring.
- 18 June 2025
- Published by SAGE Publications in Journal of Intensive Care Medicine
- Vol. 40 (11) , 1169-1176
Mortality Predictors in Stroke Patients Requiring Mechanical Ventilation: A Multicenter Prospective Observational Study
Background: Patients with acute severe stroke requiring mechanical ventilation represent a significant clinical challenge. Identification of mortality predictors is necessary to improve outcomes. Methods: Fourteen hospitals located around Russia participated in this prospective multicenter observational clinical study. Patients admitted to ICU between November 1, 2017, and November 1, 2019 with confirmed cerebral stroke, aged 18 to 90 years, and requiring mechanical ventilation were included. The impact of various clinical factors on mortality during the 28-day period after stroke was assessed. Results: A total of 1289 patients were included in the registry, and 1144 met the study criteria. The 28-day mortality rate for stroke patients on mechanical ventilation was 64.3%. The most common indications for mechanical ventilation were impaired consciousness (75.7%) and hypoxemia (60.9%). In the cohort of strokes with NIHSS severity greater than 20 points, hypoxemia at the start of ventilation (OR 1.85 [1.21; 2.81], P = 0.004) and the use of hyperventilation mode (OR 1.46 [1.02; 2.06], P = 0.0336) were associated with increased mortality. Pressure-controlled mode as the primary ventilation method (OR 0.36 [0.21; 0.60], P < 0.001) and ICP monitoring (OR 0.23 [0.12; 0.44], P < 0.001) were associated with decreased mortality. Infectious complications were associated with longer mechanical ventilation and ICU stay (P < 0.001). The relationship between probable mortality and the severity of neurological deficit on the NIHSS scale at the start of mechanical ventilation is non-linear. A critical threshold was reached at 16 points NIHSS, where a trend of increasing probable mortality emerged. Conclusion: The identified predictors of mortality in stroke patients requiring mechanical ventilation are essential for decision-making in this cohort. They include hypoxemia, hyperventilation (used to control intracranial hypertension), volume-controlled (VC) versus pressure-controlled (PC) initial ventilation, and the use of clinical methods for monitoring ICP alone versus invasive monitoring.